News

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...
The battle between weight-loss drugs continues. While studies show semaglutide (sold under the brand names Ozempic and Wegovy ...
Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.
A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...
Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...
A decision is expected in the fourth quarter of 2025.
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...